Northwest Bioth Cmn (NWBO) Social Stream



Northwest Bioth Cmn (NWBO): $1.35

0.06 (+4.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NWBO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 503

in industry

Featured Post From StockTwits About NWBO

$NWBO To get a sense of the scale and scope... Phase III trials were for nearly ten years. Data lock has already been nearly a year, raw data is being analyzed and prepared for scientific advisory boards and independent cancer experts.
As for the principal investigator, "in the late 1990s, Liau and her team were the first to test a dendritic cell–based vaccine in people with glioblastoma."
She has been after this for more than two decades.
I think she more than anyone wants to get this in the hands of the people.
poorprince, published August 15, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5712 seconds.